218 related articles for article (PubMed ID: 23875777)
1. Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.
Bertrand SJ; Mactutus CF; Aksenova MV; Espensen-Sturges TD; Booze RM
J Neurochem; 2014 Jan; 128(1):140-51. PubMed ID: 23875777
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.
Bertrand SJ; Aksenova MV; Mactutus CF; Booze RM
Exp Neurol; 2013 Oct; 248():228-35. PubMed ID: 23811015
[TBL] [Abstract][Full Text] [Related]
3. Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.
Fitting S; Knapp PE; Zou S; Marks WD; Bowers MS; Akbarali HI; Hauser KF
J Neurosci; 2014 Sep; 34(38):12850-64. PubMed ID: 25232120
[TBL] [Abstract][Full Text] [Related]
4. A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat.
Raybuck JD; Hargus NJ; Thayer SA
J Neurosci; 2017 Aug; 37(33):7837-7847. PubMed ID: 28716964
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.
Hargus NJ; Thayer SA
J Neurosci; 2013 Nov; 33(45):17908-20. PubMed ID: 24198379
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure.
Adams SM; Aksenova MV; Aksenov MY; Mactutus CF; Booze RM
PLoS One; 2012; 7(5):e37540. PubMed ID: 22629415
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids exert CB
Xu C; Hermes DJ; Nwanguma B; Jacobs IR; Mackie K; Mukhopadhyay S; Lichtman AH; Ignatowska-Jankowska B; Fitting S
Mol Cell Neurosci; 2017 Sep; 83():92-102. PubMed ID: 28733129
[TBL] [Abstract][Full Text] [Related]
8. Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.
Shin AH; Kim HJ; Thayer SA
Br J Pharmacol; 2012 Jun; 166(3):1002-17. PubMed ID: 22142193
[TBL] [Abstract][Full Text] [Related]
9. NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway.
Green MV; Thayer SA
J Neurosci; 2016 Dec; 36(50):12640-12649. PubMed ID: 27810933
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat induced microglial EVs leads to neuronal synaptodendritic injury: microglia-neuron cross-talk in NeuroHIV.
Kannan M; Singh S; Chemparathy DT; Oladapo AA; Gawande DY; Dravid SM; Buch S; Sil S
Extracell Vesicles Circ Nucl Acids; 2022; 3(2):133-149. PubMed ID: 36812097
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol.
Bertrand SJ; Hu C; Aksenova MV; Mactutus CF; Booze RM
Front Microbiol; 2015; 6():894. PubMed ID: 26441850
[TBL] [Abstract][Full Text] [Related]
12. HIV Tat Protein Selectively Impairs CB
Wu MM; Thayer SA
eNeuro; 2020; 7(3):. PubMed ID: 32471847
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures.
Shin AH; Thayer SA
Mol Cell Neurosci; 2013 May; 54():22-9. PubMed ID: 23267846
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.
Kim HJ; Martemyanov KA; Thayer SA
J Neurosci; 2008 Nov; 28(48):12604-13. PubMed ID: 19036954
[TBL] [Abstract][Full Text] [Related]
15. GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration.
Hermes DJ; Yadav-Samudrala BJ; Xu C; Paniccia JE; Meeker RB; Armstrong ML; Reisdorph N; Cravatt BF; Mackie K; Lichtman AH; Ignatowska-Jankowska BM; Lysle DT; Fitting S
Exp Neurol; 2021 Jul; 341():113699. PubMed ID: 33736974
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior.
Hahn YK; Podhaizer EM; Farris SP; Miles MF; Hauser KF; Knapp PE
Brain Struct Funct; 2015 Mar; 220(2):605-23. PubMed ID: 24352707
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Protein Tat
Liu Y; Zhou D; Feng J; Liu Z; Hu Y; Liu C; Kong X
Virol Sin; 2018 Jun; 33(3):261-269. PubMed ID: 29737506
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway.
De Simone FI; Darbinian N; Amini S; Muniswamy M; White MK; Elrod JW; Datta PK; Langford D; Khalili K
J Neuroimmune Pharmacol; 2016 Jun; 11(2):358-68. PubMed ID: 27032771
[TBL] [Abstract][Full Text] [Related]
19. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death.
Suzuki M; El-Hage N; Zou S; Hahn YK; Sorrell ME; Sturgill JL; Conrad DH; Knapp PE; Hauser KF
Mol Neurodegener; 2011 Nov; 6():78. PubMed ID: 22093090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
